Revvity
Christopher Ayres is a seasoned sales professional with extensive experience in the life sciences sector. Currently serving as a Senior Sales Specialist at Revvity since May 2023, Christopher previously held a similar role at PerkinElmer, Inc., specializing in Discovery Reagents, since April 2021. Prior to that, Christopher spent several years at ABclonal Technology, where responsibilities included managing significant B2C accounts and achieving notable sales performance. Early career roles include positions as a Technical Sales Specialist and Sales Support Specialist at ABclonal, as well as logistics roles at NeoScientific. Christopher's educational background includes a Bachelor of Science in Chemistry from William & Mary, completed in 2015.
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com